Novel 660 300 mg (Trimethobenzamide hydrochloride 300 mg)

Pill imprint Novel 660 300 mg has been identified as Trimethobenzamide hydrochloride 300 mg.

Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Novel 660 300 mg

Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride
Imprint:
Novel 660
300 mg
Strength:
300 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gavis Pharmaceuticals
National Drug Code (NDC):
43386-0660
Inactive Ingredients:
lactose monohydrate
magnesium stearate
corn starch
D&C Red No. 28
gelatin
FD&C Blue No. 1
FD&C Red No. 40
titanium dioxide
soya lecithin
water
shellac
ethylene glycol monoethyl ether

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)